Pharma Focus Europe

Amgen Invests US$1 billion to Open New Manufacturing Site in US

Introduction:

Amgen with an investment of US$1 billion plans to open new manufacturing site. It will be the second manufacturing plant located in US.

Features:

The new manufacturing facility is designed with most advanced technologies to support the production of medicines.

Together with previously announced plans to build a new packaging plant, the company invests an additional US$1billion in manufacturing capacity to boost the increasing growth of medicines.

The new plantallows flexibility for multiple pipeline products in one plant focusing on both traditional stainless steel-fed batch manufacturing and next-generation single-use technologies.

The construction of the new plant is expected to begin in December 2021, and complete by late 2024.

The new facility is expected to generate a total of 355 full-time jobs including technicians, engineers, quality, management and administrative roles by the end of 2029.

Specifications:

NameAmgen
TypeNew manufacturing Facility
BudgetUS$1 Billion
Year2024
magazine-slider-img
Thermo Fisher Scientific - mRNA ServicesWorld Orphan Drug Congress 2024World Vaccine Congress Europe 2024Advanced Therapies USA 2024
cytiva